Pathophysiological analyses of skeletal muscle in obese type 2 diabetes SDT fatty rats
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Sarcopenia is the age-related decrease of muscle mass and function. Diabetes and obesity are known to be risk factors that exacerbate sarcopenia, but the underlying mechanism of diabetes-related sarcopenia is still unknown. Obese type 2 diabetes SDT fatty rats show early onset of severe diabetes and there have been no reports on the characteristics of their skeletal muscle. Therefore, pathophysiological analyses were performed for the skeletal muscle in these rats. Diabetic male SDT fatty rats were sacrificed at 8, 16, 24, 32 and 40 weeks of age. Age-matched Sprague Dawley (SD) rats were used as the normal control. In addition to biological blood parameters, the soleus and the extensor digitorum longus muscles were examined for muscle weight, histopathology, and protein synthesis and degradation. Muscle grip strength was also examined. These results revealed that the muscle weights of the SDT fatty rats were significantly decreased from 16 weeks of age. The mean cross-sectional area of muscle fibers in the SDT fatty rats decreased from 24 weeks of age. Increased intramyocellular lipid accumulation, identified by immunohistochemistry for adipophilin and TEM, was observed in the SDT fatty rats from 8 weeks of age. Plasma insulin-like growth factor (IGF)-1 levels and muscle strength in the SDT fatty rats decreased at 24 weeks of age and thereafter. These pathophysiological findings have been reported both in sarcopenia in aged humans and in patients with diabetes. In conclusion, the SDT fatty rat was considered to be a useful model for analysis of diabetes-related sarcopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Animal studies have shown69 that diabetes mellitus leads to reduced skeletal muscle weight, strength, and cross-sectional area of muscle fibers, while intramyocellular (IMCL) lipid content increases.”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Fiber Types in Mammalian Skeletal Muscles
Schiaffino, S., & Reggiani, C. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2010 · Cited by 3,022
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102
Sarcopenia: alternative definitions and associations with lower extremity function
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., et al. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51534.x · Cited by 981
An overview of sarcopenia: facts and numbers on prevalence and clinical impact
von Haehling, S., Morley, J. E., & Anker, S. D. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0014-2 · Cited by 888
Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., Kuller, L. H., Broudeau, R., Kammerer, C., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2537 · Cited by 766
Morley, J. E., Anker, S. D., & von Haehling, S. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0161-y · Cited by 608
Wang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006) · Endocrinology · doi:10.1210/en.2006-0251 · Cited by 600
Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
Sarcopenia: Definition, Epidemiology, and Pathophysiology
Kim, T. N., & Choi, K. M. (2013) · Journal of Bone Metabolism · doi:10.11005/jbm.2013.20.1.1 · Cited by 502
Cited by
Journal of Cachexia, Sarcopenia and Muscle
(2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/13539.2190-6009 · Cited by 215
Nachit, M., & Leclercq, I. A. (2019) · Clinical Science · doi:10.1042/cs20180421 · Cited by 73
Yamamoto, Y. L., Nagai, Y., Kawanabe, S., Hishida, Y., Hiraki, K., Sone, M., & Tanaka, Y. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0550 · Cited by 70
“According to an animal model for the analysis of diabetes-related sarcopenia [24], disruption to insulin/ insulin-like growth factor-1 (IGF-1)-Akt signaling due to insulin resistance and low serum IGF-1 levels reduced muscle protein synthesis and provoked abnormalities in muscle strength and mass.”
MethodThe impact of a high-fat diet in mice is dependent on duration and age, and differs between muscles
Messa, G. A. M., Piasecki, M., Hurst, J., Hill, C., Tallis, J., & Degens, H. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.217117 · Cited by 63
Liang, Y., Yang, I., Lin, Y.-W., Lin, J., Wu, C., Chiang, C., Lai, K.-H., & Lin, F. (2021) · Antioxidants · doi:10.3390/antiox10040616 · Cited by 38
“Grip strength was measured using a grip strength meter (Columbus Instruments, Columbus, OH, USA), according to a previous report [23].”
Method
Metadata
- Authors
- Kemmochi, Y., Ohta, T., Motohashi, Y., Kaneshige, A., Katsumi, S., Kakimoto, K., Yasui, Y., Anagawa-Nakamura, A., Toyoda, K., Taniai-Riya, E., Takahashi, A., Shoda, T., & Yamada, T.
- Affiliations
- Japan Tobacco (Japan) (JP)
- Toxicology Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 23 Naganuki, Hadano, Kanagawa 257-0024, Japan
- Niigata University (JP)
- Corresponding author
- Kemmochi, Yusuke
- Venue
- Journal of Toxicologic Pathology
- Published
- 2018
- Volume
- 31
- Issue
- 2
- Pages
- 113-123
- ISSN
- 0914-9198 (ISSN-L)
- 1881-915X
- PMC
- PMC5938212
- OpenAlex
- W2794151638
- Cited by
- 23
- References
- 41
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 7 · 2020: 4 · 2019: 1 · 2018: 3
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Journal of Toxicologic Pathology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- sarcopenia, type 2 diabetes, obesity, skeletal muscle, adipophilin, insulin-like growth factor I, muscle strength, muscle fiber cross-sectional area
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiological analyses of skeletal muscle in obese type 2 diabetes SDT fatty rats. https://app.cochat.ai/papers/10.1293/tox.2017-0064
- The paper
- Kemmochi, Y., Ohta, T., Motohashi, Y., Kaneshige, A., Katsumi, S., Kakimoto, K., Yasui, Y., Anagawa-Nakamura, A., Toyoda, K., Taniai-Riya, E., Takahashi, A., Shoda, T., & Yamada, T. (2018). Pathophysiological analyses of skeletal muscle in obese type 2 diabetes SDT fatty rats. Journal of Toxicologic Pathology. https://doi.org/10.1293/tox.2017-0064
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.